Reduced-dose whole-brain radiotherapy with tumor bed boost after upfront high-dose methotrexate for primary central nervous system lymphoma
Tae Hoon Lee, Joo Ho Lee, Ji Hyun Chang, Sung-Joon Ye, Tae Min Kim, Chul-Kee Park, Il Han Kim, Byoung Hyuck Kim, Chan Woo Wee
Radiat Oncol J. 2020;38(1):35-43.   Published online 2020 Mar 25     DOI:
Citations to this article as recorded by Crossref logo
Is There an Indication for First Line Radiotherapy in Primary CNS Lymphoma?
Clemens Seidel, Christine Viehweger, Rolf-Dieter Kortmann
Cancers.2021; 13(11): 2580.     CrossRef
Role of 23.4 Gy upfront whole-brain radiation therapy following high-dose methotrexate for primary central nervous system lymphoma: a comparative analysis of whole-brain radiation therapy versus no radiation therapy
Nalee Kim, Do Hoon Lim, Sang Eun Yoon, Seok Jin Kim, Won Seog Kim
Journal of Neuro-Oncology.2021; 154(2): 207.     CrossRef
Advances in treatment of elderly primary central nervous system lymphoma
Nicolas Martinez‐Calle, Lisa K. Isbell, Kate Cwynarski, Elisabeth Schorb
British Journal of Haematology.2021;[Epub]     CrossRef
Faut-il moduler les contraintes de dose dans les organes à risque lors d’une irradiation en association avec un traitement anticancéreux systémique ?
E. Jouglar, J. Doyen, S. Supiot
Cancer/Radiothérapie.2020; 24(6-7): 594.     CrossRef